Healthcare NSE: DRREDDY

Dr. Reddy's Laboratories Financial Statements, P/E Ratio & ROE Valuation

Dr. Reddy's Laboratories (DRREDDY) — Drug Manufacturers - Specialty & Generic

₹1,171.00 INR

▼ ₹5.00 (-0.43%)

Overview Share Price Financials & P/E Dividends Shareholding Peer Comparison

Dr. Reddy's Laboratories Financial Statements & Valuation Multiples

✨ Financials & Valuation Analysis

Dr. Reddy's Laboratories trades at a balanced P/E of 29.45912, reflecting strong institutional market trust and consistent compound returns.

P/E Ratio (TTM) 29.45912

Forward P/E 19.716324

Price-to-Book (P/B) 2.5439599

Return on Equity (ROE) 8.84%

Profit Margin 10%

Operating Margin 4.25%

EPS (TTM) ₹39.75

Enterprise Value ₹96925.64 Cr

Financial Health & Profitability Breakdown for Dr. Reddy's Laboratories

A comprehensive review of Dr. Reddy's Laboratories reveals an ROE of 8.84% and operating profitability margins of 4.25%. Dr. Reddy's Laboratories maintains high capital efficiency with an ROE of 8.84% and operating margins of 4.25%, demonstrating robust cash generation capabilities.

Evaluating valuation metrics, Dr. Reddy's Laboratories maintains a Price-to-Earnings ratio of 29.45912 and a Price-to-Book multiple of 2.5439599. These valuation metrics, combined with an Enterprise Value of ₹96925.64 Cr, provide essential indicators for fundamentally driven stock selection in India's Healthcare sector.

Frequently Asked Questions

What is Dr. Reddy's Laboratories P/E ratio and Price-to-Book (P/B) ratio?

Dr. Reddy's Laboratories trades at a trailing P/E of 29.45912, a Forward P/E of 19.716324, and a P/B ratio of 2.5439599.

What is Dr. Reddy's Laboratories Return on Equity (ROE)?

Dr. Reddy's Laboratories reports a Return on Equity (ROE) of 8.84%, reflecting shareholder capital efficiency.

What are Dr. Reddy's Laboratories profit margin and operating margin?

Dr. Reddy's Laboratories maintains a net profit margin of 10% and an operating margin of 4.25%.

What is Dr. Reddy's Laboratories Enterprise Value and EBITDA multiplier?

Dr. Reddy's Laboratories has an Enterprise Value of ₹96925.64 Cr and reported earnings per share (TTM EPS) of ₹39.75.

Explore Similar Healthcare Stocks

Explore Categories:

Technology Stocks Banking Stocks Nifty 50 Stocks Dividend Stocks Large Cap Stocks